Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5184912
Max Phase: Preclinical
Molecular Formula: C18H12ClFN2O
Molecular Weight: 326.76
Associated Items:
ID: ALA5184912
Max Phase: Preclinical
Molecular Formula: C18H12ClFN2O
Molecular Weight: 326.76
Associated Items:
Canonical SMILES: Fc1ccccc1C1=NC(c2ccco2)Nc2ccc(Cl)cc21
Standard InChI: InChI=1S/C18H12ClFN2O/c19-11-7-8-15-13(10-11)17(12-4-1-2-5-14(12)20)22-18(21-15)16-6-3-9-23-16/h1-10,18,21H
Standard InChI Key: MRRBXGSNHRUKCR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 326.76 | Molecular Weight (Monoisotopic): 326.0622 | AlogP: 5.03 | #Rotatable Bonds: 2 |
Polar Surface Area: 37.53 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.97 | CX Basic pKa: 1.58 | CX LogP: 4.83 | CX LogD: 4.83 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.72 | Np Likeness Score: -0.95 |
1. Deka B, Suri M, Sarma S, Devi MV, Bora A, Sen T, Dihingia A, Pahari P, Singh AK.. (2022) Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor., 54 [PMID:34953341] [10.1016/j.bmc.2021.116580] |
Source(1):